tiprankstipranks
Trending News
More News >
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Technical Analysis

Compare
489 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
C4 Therapeutics’s (CCCC) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting C4 Therapeutics is a Sell.
C4 Therapeutics’s (CCCC) 20-Day exponential moving average is 1.53, while C4 Therapeutics’s (CCCC) share price is $1.62, making it a Buy.
C4 Therapeutics’s (CCCC) 50-Day exponential moving average is 2.01, while C4 Therapeutics’s (CCCC) share price is $1.62, making it a Sell.

C4 Therapeutics (CCCC) Pivot Points

Apr 30, 2025, 08:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.33
1.41
1.47
1.56
1.62
1.70
1.77
Fibonacci
1.41
1.47
1.50
1.56
1.61
1.65
1.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

C4 Therapeutics (CCCC) Moving Averages

Apr 30, 2025, 08:33 AM
Period
Simple
Exponential
MA5
1.59Buy
1.55Buy
MA10
1.41Buy
1.49Buy
MA20
1.38Buy
1.53Buy
MA50
1.99Sell
2.01Sell
MA100
2.90Sell
2.78Sell
MA200
4.38Sell
3.91Sell
C4 Therapeutics’s (CCCC) 10-Day exponential moving average is 1.49, while C4 Therapeutics’s (CCCC) share price is $1.62, making it a Buy.
C4 Therapeutics’s (CCCC) 100-Day exponential moving average is 2.78, while C4 Therapeutics’s (CCCC) share price is $1.62, making it a Sell.
C4 Therapeutics’s (CCCC) stock price is $1.62 and C4 Therapeutics’s (CCCC) 50-day simple moving average is 1.99, creating a Sell signal.
C4 Therapeutics’s (CCCC) stock price is $1.62 and C4 Therapeutics’s (CCCC) 100-day simple moving average is 2.90, creating a Sell signal.
C4 Therapeutics’s (CCCC) stock price is $1.62 and C4 Therapeutics’s (CCCC) 200-day simple moving average is 4.38, creating a Sell signal.

C4 Therapeutics (CCCC) Technical Indicators

Apr 30, 2025, 08:33 AM
Name
Value
Implied Action
RSI (14)
50.00
Neutral
STOCH (9,6)
76.92
Neutral
STOCHRSI (14)
77.10
Neutral
MACD (12,26)
-0.13
Sell
ADX (14)
36.15
Neutral
Williams %R
-18.32
Sell
CCI (14)
102.20
Sell
ATR (14)
0.17
-
Ultimate Oscillator
57.89
Neutral
ROC
21.80
Buy
C4 Therapeutics’s (CCCC) Relative Strength Index (RSI) is 50.00, creating a Neutral signal.
C4 Therapeutics’s (CCCC) Trend Strength Indicator (ADX) is 36.15, creating a Neutral signal.
C4 Therapeutics’s (CCCC) Commodity Channel Index (CCI) is 102.20, creating a Sell signal.
C4 Therapeutics’s (CCCC) Price Rate of Change (ROC) is 21.80, creating a Buy signal.

FAQ

Is CCCC a Buy, Hold, or Sell?
Based on CCCC’s technical indicators, CCCC is a Hold.
    What is CCCC’s RSI (14)?
    CCCC’s RSI (14) is 50.00, which suggests CCCC is a Neutral.
      What is CCCC’s MACD?
      CCCC’s MACD is -0.13, which suggests CCCC is a Sell.
        What is CCCC’s 5-day moving average?
        CCCC’s 5-day moving average is 1.59, which suggests CCCC is a Buy.
          What is CCCC’s 20-day moving average?
          CCCC 20-day moving average is 1.38, which suggests CCCC is a Buy.
            What is CCCC’s 50-day moving average?
            CCCC’s 50-day moving average is 1.99, which suggests CCCC is a Sell.
              What is CCCC’s 200-day moving average?
              CCCC’s 200-day moving average is 4.38, which suggests CCCC is a Sell.
                What is CCCC’s Williams % R (14)?
                CCCC’s Williams % R (14) is -18.32, which suggests CCCC is a Sell.
                  What is CCCC’s CCI (14)?
                  CCCC’s CCI (14) is 102.20, which suggests CCCC is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis